glp-1 vs compounded semaglutide or Tirzepatide—which is right for you? Swipe to learn how each treatment works, the difference between and GIP, and how a licensed provider can help you find the best fit Compounded Semaglutide: Safety & Regulation

Request diagnostic assessments to ensure accurate diagnosis and treatment of co-occurring mental health conditions

These are boxed warnings or precautions across the approved GLP-1 class and should be assumed for retatrutide pending full FDA labeling

Their effect is more modest, but they are orally available and generally well tolerated

In a parallel matched cohort of 37,740 patients with both IBD and T2D, GLP-1 RA users had a 5-year colorectal cancer incidence of 0.31% vs 0.57% in non-users (OR, 0.54), representing a 46% reduction in odds

Tirzepatide targets two appetite pathways, but it is not right for everyone, results vary, and no medication is guaranteed

However, these costs are usually proportional to the potential recovery